Evidence map›Paper›PMID 31077177›Full record

ArticleBMC endocrine disorders2019

Changes of serum 25(OH) D3 and IGF-1 levels in patients with thyroid nodules.

Xueqin Du, Yi Liu, Chunhui Zhao, Jingzhou Fang, Xiangna Wang, Limin Wei

Open access · goldAbstract read
In one paragraph

Article in BMC endocrine disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Association ofAnalytical cellular pathology (Amsterdam) · 2025
    Article
  4. Vitamin D and the Thyroid: A Critical Review of the Current Evidence.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Xueqin DuHebei Medical University, Shijiazhuang, 050017, Hebei, China.
Yi LiuHebei North University, Zhangjiakou, 075000, Hebei, China.
Chunhui ZhaoDepartment of Pediatrics, Shijiazhuang Fourth Hospital, Shijiazhuang, 050011, Hebei, China.
Jingzhou FangHebei North University, Zhangjiakou, 075000, Hebei, China.
Xiangna WangHebei North University, Zhangjiakou, 075000, Hebei, China.
Limin WeiDepartment of Endocrinology, Hebei General Hospital, Shijiazhuang, 050051, Hebei, China. 15133130672@163.com.
Hebei North University · CNHebei Medical University · CNHebei General Hospital · CN

Funding

Government-funded project for outstanding clinical talents of Hebei 361003Mandatory plan for major research projects in medical science research of Hebei 20160077
6 · The paper itself

Abstract

backgroundThe present study aimed to study the relationship between serum 25 hydroxyvitamin D3(25(OH)D3) and insulin-like growth factor-1 (IGF-1) and thyroid nodules.

methodsTwo hundred eighty-nine cases with thyroid nodules and 109 health subjects (control group) who admitted to the Hebei General Hospital during June 2016 to December 2016 were included in the study. Basic clinical information (age, sex, thyroid function, liver and kidney function, hypertension history, etc.) of patients were collected. Serum 25(OH) D3 and Serum IGF-1 were detected by electrochemiluminescence and radioimmunoassay methods, respectively. The relationship between the above-mentioned factors and thyroid nodules was statistically analyzed.

resultsSerum 25(OH)D3, IGF-1, fasting blood glucose (FBG), total cholesterol (TC), waist circumference (WC), total triiodothyronine (TT3), total thyroxine (TT4), hypertension history, and drinking history were significantly different between the nodules group and the control group (P < 0.05). Logistic regression analysis showed that there was a negative correlation between thyroid nodules and levels of 25(OH)D3, IGF-1, TT3, as well as a positive correlation with FBG, TC, TT4, and hypertension. There was a positive correlation between IGF-1 and serum 25(OH)D3 in thyroid nodules (P < 0.05). After correcting the aforementioned factors, high-level of serum 25(OH)D3 was significantly correlated with the decreased incidence of thyroid nodules.

conclusionsThe incidence of thyroid nodules is relatively lower in a high-level of serum 25(OH)D3, and serum 25(OH)D3 may be a direct protective factor for thyroid nodules. Serum IGF-1 can be one of the indirect protective factors for thyroid nodules as well.

Indexed as

AdultBiomarkersBody Mass IndexCalcifediolCase-Control StudiesChinaFemaleFollow-Up StudiesHumansInsulin-Like Growth Factor IMaleMiddle AgedPrognosisThyroid NoduleTriiodothyronineBiomarkersCalcifediolIGF1 protein, humanInsulin-Like Growth Factor ITriiodothyronine25(oh)D3Correlation analysisDeficiency of vitamin DInsulin-like growth factor-1Thyroid nodules

Identifiers

PMID31077177
PMCPMC6509827
OpenAlexW2947615801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.